Gene One Problem Definition :: Business Strategy Analysis

To grow or not to grow, that is the dilemma. Many companies are often faced with this challenging decision. The consequences of this decision whitethorn be the overall victory or failure of the organization. Change is often necessary to create opportunities for growth and profitability. In fact, change is required for companies looking to grow the business (Andersen, 2005). Such changes may include modifying the existing culture of the organization and the companys leadership philosophy. McShane and Von Glinow (2004) define organizational culture as the set of core values, beliefs and behaviors shared by the members of an organization. Culture determines how semi-formal or informal an office is, how much emphasis is placed on rules and regulations, how approachable senior management is, how problems are tackled and successes shared, etc. It is important, particularly in propagation of change, for companies to have a clear sense of who they are, what they stand for and what behavio rs their people must exhibit for the organization to be successful. Having a clear vision has a confident(p) impact on the organization and its employees. Having a strong sense of who the company is and what it stands for promotes an environment where people demonstrate a commitment to the companys core values, such as providing excellent customer service, being dedicated to quality, acting with integrity, and showing respect for each other. These values keep the company on course, regardless of the changes and challenges that are faced. nerve centre values enable the company to not just weather the difficult times, but to come through them an even stronger organization. This paper explores the challenges and opportunities faced by ingredient One and identifies end state goals used to measure success. It will show the benefits of revamping the existing culture of an organization in an effort to drive business results and go through growth and profitability. Gene One, faced wit h increasing demands in the biotech industry, is challenged to grow the business 40 percent per year for three years, become a publicly traded company, nobble capital and develop new products. The company has experienced rapid growth, growing annual revenue from $2 million to $400 million over its low eight years. The CEO and Executive Board of Gene One are implementing the strategy to become a public company in order to light upon access to the much needed capital for new product development and marketing.